BFC Planning’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$327K Buy
767
+266
+53% +$109K 0.01% 755
2026
Q2
$195K Buy
501
+31
+7% +$13.1K 0.01% 939
2026
Q1
$222K Buy
470
+28
+6% +$14.1K 0.01% 841
2025
Q4
$206K Sell
442
-1
-0.2% -$464 0.01% 862
2025
Q3
$189K Buy
443
+4
+0.9% +$1.55K 0.01% 684
2025
Q2
$168K Buy
439
+54
+14% +$19.5K 0.01% 696
2025
Q1
$133K Buy
385
+2
+0.5% +$643 0.01% 761
2024
Q4
$115K Sell
383
-44
-10% -$15.4K 0.01% 802
2024
Q3
$174K Buy
+427
New +$156K 0.02% 656

Other funds holding HCA

BFC Planning's HCA Position: Q3 2026 in Review

BFC Planning increased its HCA Healthcare (HCA) stake by 53% in Q3 2026, buying an estimated $109K and bringing the position to 767 shares worth $327K. The position accounts for 0.01% of the portfolio, ranked #755.

BFC Planning first reported a position in HCA in Q3 2024 and has held it in 9 quarters since. 1,138 funds tracked by Wall St. Rank hold HCA as of Q3 2026.

  • BFC Planning held 767 shares of HCA Healthcare worth $327K as of Q3 2026.
  • BFC Planning bought 266 HCA Healthcare shares in Q3 2026, an estimated $109K.
  • HCA Healthcare made up 0.01% of BFC Planning's portfolio in Q3 2026, its #755 holding.
  • BFC Planning first reported a position in HCA Healthcare in Q3 2024 and has held it in 9 quarters since.
  • 1,138 funds tracked by Wall St. Rank held HCA Healthcare as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.